These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37564471)

  • 21. Epstein-Barr virus-encoded LMP1 interacts with FGD4 to activate Cdc42 and thereby promote migration of nasopharyngeal carcinoma cells.
    Liu HP; Chen CC; Wu CC; Huang YC; Liu SC; Liang Y; Chang KP; Chang YS
    PLoS Pathog; 2012; 8(5):e1002690. PubMed ID: 22589722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of tumor necrosis factor receptor-associated factor 1 in nasopharyngeal carcinoma: possible upregulation by Epstein-Barr virus latent membrane protein 1.
    Siegler G; Meyer B; Dawson C; Brachtel E; Lennerz J; Koch C; Kremmer E; Niedobitek E; Gonnella R; Pilch BZ; Young LS; Niedobitek G
    Int J Cancer; 2004 Nov; 112(2):265-72. PubMed ID: 15352039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
    J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of Epstein-Barr virus latent membrane protein 1 gene in the nasopharyngeal swabs from patients with nasopharyngeal carcinoma.
    Lin SY; Tsang NM; Kao SC; Hsieh YL; Chen YP; Tsai CS; Kuo TT; Hao SP; Chen IH; Hong JH
    Head Neck; 2001 Mar; 23(3):194-200. PubMed ID: 11428449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma.
    Liu L; Zuo L; Yang J; Xin S; Zhang J; Zhou J; Li G; Tang J; Lu J
    Cancer Med; 2019 Jun; 8(6):3142-3151. PubMed ID: 31063269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.
    Yang GD; Huang TJ; Peng LX; Yang CF; Liu RY; Huang HB; Chu QQ; Yang HJ; Huang JL; Zhu ZY; Qian CN; Huang BJ
    PLoS One; 2013; 8(10):e78355. PubMed ID: 24194922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LMP1 expression is positively associated with metastasis of nasopharyngeal carcinoma: evidence from a meta-analysis.
    Zhao Y; Wang Y; Zeng S; Hu X
    J Clin Pathol; 2012 Jan; 65(1):41-5. PubMed ID: 22039283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NF-κB-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma.
    Chen CC; Liu HP; Chao M; Liang Y; Tsang NM; Huang HY; Wu CC; Chang YS
    Oncogene; 2014 Jul; 33(28):3648-59. PubMed ID: 23975427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repression of DERL3 via DNA methylation by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.
    Kondo S; Okabe A; Nakagawa T; Matsusaka K; Fukuyo M; Rahmutulla B; Dochi H; Mizokami H; Kitagawa Y; Kurokawa T; Mima M; Endo K; Sugimoto H; Wakisaka N; Misawa K; Yoshizaki T; Kaneda A
    Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166598. PubMed ID: 36372158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitogen- and stress-activated Kinase 1 mediates Epstein-Barr virus latent membrane protein 1-promoted cell transformation in nasopharyngeal carcinoma through its induction of Fra-1 and c-Jun genes.
    Li B; Wan Z; Huang G; Huang Z; Zhang X; Liao D; Luo S; He Z
    BMC Cancer; 2015 May; 15():390. PubMed ID: 25958199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus latent membrane protein 1 (LMP1) regulates the aldehyde dehydrogenase (ALDH) positive cell population in nasopharyngeal carcinoma cell lines.
    Wu J; Su H; Li G; Huang Y
    Acta Virol; 2019; 63(3):322-327. PubMed ID: 31507199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
    Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
    Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of EBV proteins LMP1 and BHFR1 in EBV‑associated gastric and nasopharyngeal cancer tissues.
    Wang A; Zhang W; Jin M; Zhang J; Li S; Tong F; Zhou Y
    Mol Med Rep; 2016 May; 13(5):4151-8. PubMed ID: 27052804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis.
    Liu LN; Huang PY; Lin ZR; Hu LJ; Liang JZ; Li MZ; Tang LQ; Zeng MS; Zhong Q; Zeng BH
    J Transl Med; 2013 Jun; 11():140. PubMed ID: 23758975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Application of EB virus latent membrane protein 1 in nasopharyngeal swab in diagnosis of nasopharyngeal carcinoma].
    Xie Y; Huang G; Zhang Z; Wen W; Wu Y; Wei Z
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Jun; 20(11):499-501. PubMed ID: 16929830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway.
    Yang CF; Peng LX; Huang TJ; Yang GD; Chu QQ; Liang YY; Cao X; Xie P; Zheng LS; Huang HB; Cai MD; Huang JL; Liu RY; Zhu ZY; Qian CN; Huang BJ
    Cancer Lett; 2014 Mar; 344(2):260-71. PubMed ID: 24262659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes.
    Yang Q; Lin H; Wu S; Lei F; Zhu X; Song L; Hong M; Guo L
    PLoS One; 2015; 10(8):e0136448. PubMed ID: 26305455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas.
    Liao WH; Yang LF; Liu XY; Zhou GF; Jiang WZ; Hou BL; Sun LQ; Cao Y; Wang XY
    BMC Cancer; 2014 Nov; 14():835. PubMed ID: 25407966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in the immunogenicity of latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinoma.
    Hu L; Troyanovsky B; Zhang X; Trivedi P; Ernberg I; Klein G
    Cancer Res; 2000 Oct; 60(19):5589-93. PubMed ID: 11034108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.